Montelukast Sodium
Product Images NDC 42254-263

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Montelukast Sodium (NDC 42254-263). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rebel Distributors Corp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Figure 1 (A4f92eb4 0df1 4300 Aebd 6082fe804ac8 01)

Figure 1 (A4f92eb4 0df1 4300 Aebd 6082fe804ac8 01)
FDA Label Image

Chemical Structure (A4f92eb4 0df1 4300 Aebd 6082fe804ac8 02)

Chemical Structure (A4f92eb4 0df1 4300 Aebd 6082fe804ac8 02)
FDA Label Image

Figure 2 (A4f92eb4 0df1 4300 Aebd 6082fe804ac8 03)

Figure 2 (A4f92eb4 0df1 4300 Aebd 6082fe804ac8 03)
This appears to be a graph or chart indicating the Mean Percent Change from Baseline over 15 weeks in a treatment that includes 9 weeks of "Montelukast Sodium" and 6 weeks of "Washout". The chart also includes a comparison to a placebo treatment.*
FDA Label Image

Montelukast Sodium (A4f92eb4 0df1 4300 Aebd 6082fe804ac8 04)

Montelukast Sodium (A4f92eb4 0df1 4300 Aebd 6082fe804ac8 04)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.